Health and Healthcare
579 Articles
Baxter International is taking an activist investor role of its own. The health care company has announced that it is…
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…
In Deutsche Bank's monthly quant view research piece, the firm looks for strategies that investors can implement to limit their…
If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List…
GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews…
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013.…
Jon OggWe are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new…
ThinkstockThe saying is that if there is a trading strategy, then there is an ETF strategy for that as well.…
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…
ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own…
ThinkstockAbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted…
Our top personal finance-related articles today. Your wallet will thank you later.